0001104659-23-019778.txt : 20230213 0001104659-23-019778.hdr.sgml : 20230213 20230213164936 ACCESSION NUMBER: 0001104659-23-019778 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230213 DATE AS OF CHANGE: 20230213 EFFECTIVENESS DATE: 20230213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Foresite Capital Management IV, LLC CENTRAL INDEX KEY: 0001704132 IRS NUMBER: 821204449 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18415 FILM NUMBER: 23619367 BUSINESS ADDRESS: STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150 CITY: LARKSPUR STATE: CA ZIP: 94939 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150 CITY: LARKSPUR STATE: CA ZIP: 94939 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false false false 0001704132 XXXXXXXX 12-31-2022 12-31-2022 false Foresite Capital Management IV, LLC

900 Larkspur Landing Circle, Suite 150 Larkspur CA 94939

13F HOLDINGS REPORT 028-18415 N James B. Tananbaum 415-877-4887 /s/ James B. Tananbaum San Francisco CA 02-10-2023 0 8 234124533 INFORMATION TABLE 2 infotable.xml Aclaris Therapeutics, Inc. COM 00461U105 44226536 2808034 SH SOLE 2808034 0 0 Cymabay Therapeutics, Inc. COM 23257D103 11205079 1787094 SH SOLE 1787094 0 0 Kinnate Biopharma Inc. COM 49705R105 58997022 9671643 SH SOLE 9671643 0 0 Kura Oncology, Inc. COM 50127T109 22957842 1849947 SH SOLE 1849947 0 0 Lyell Immunopharma, Inc. COM 55083R104 34700000 10000000 SH SOLE 10000000 0 0 Pharvaris N.V. COM N69605108 36527918 3246926 SH SOLE 3246926 0 0 Quantum-Si Incorporated COM CL A 74765K105 3241386 1771249 SH SOLE 1771249 0 0 Syndax Pharmaceuticals, Inc. COM 87164F105 22268750 875000 SH SOLE 875000 0 0